Testing effectiveness (Phase 2)Study completedNCT03170609
What this trial is testing
A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age
Who this might be right for
Group B Streptococcal Infections
Pfizer 365